Aromatase and endometriosis: Estrogens play a role

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 17-23

  Ferrero, Simone ^a   Remorgida, Valentino ^a   Maganza, Carlo ^a   Venturini, Pier Luigi ^a   Salvatore, Stefano ^b   Papaleo, Enrico ^b   Candiani, Massimo ^b   Leone Roberti Maggiore, Umberto ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Aromatase; Endometriosis; Estrogen; Inflammation

Indexed keywords

ANASTROZOLE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR; GONADORELIN; GROWTH FACTOR; HYDROXYSTEROID DEHYDROGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LETROZOLE; MACROPHAGE MIGRATION INHIBITION FACTOR; PRINABEREL; PROSTAGLANDIN E2; PROSTAGLANDIN G2; PROSTAGLANDIN SYNTHASE; RALOXIFENE; SCATTER FACTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROIDOGENIC FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENDOMETRIOSIS; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; HORMONE SUBSTITUTION; HUMAN; MACROPHAGE ACTIVATION; NONHUMAN; OVARY CYST; PELVIS PAIN SYNDROME; PERITONEUM MACROPHAGE; POSITIVE FEEDBACK; POSTMENOPAUSE; PROSTAGLANDIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AROMATASE; ENDOMETRIOSIS; ESTROGEN; INFLAMMATION;

AROMATASE; AROMATASE INHIBITORS; BIOSYNTHETIC PATHWAYS; ENDOMETRIOSIS; ESTROGENS; FEMALE; HUMANS; INFLAMMATION MEDIATORS;

EID: 84901504460     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12411     Document Type: Article

References (61)

1. Sampson, JA. 1927. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obst. Gynecol. 14: 442-469.
2. Halme, J., M.G. Hammond, J.F. Hulka, et al. 1984. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol. 64: 151-154.
3. Ferrero, S., E. Arena, A. Morando & V. Remorgida 2010. Prevalence of newly diagnosed endometriosis in women attending the general practitioner. Int. J. Gynaecol. Obstet. 110: 203-207.
4. Morotti, M., V. Remorgida, P.L. Venturini & S. Ferrero 2012. Endometriosis in menopause: a single institution experience. Arch. Gynecol. Obstet. 286: 1571-1575.
5. Goh, J.T. & B.A. Hall 1992. Postmenopausal endometrioma and hormonal replacement therapy. Aust. NZ J. Obstet. Gynaecol. 32: 384-385.
6. Fedele, L., S. Bianchi, G. Zanconato, et al. 2000. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum. Am. J. Obstet. Gynecol. 183: 1462-1467.
7. Bulun, S.E. 2009. Endometriosis. N. Engl. J. Med. 360: 268-279.
8. Michael, M.D., L.F. Michael & E.R. Simpson 1997. A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene. Mol. Cell Endocrinol. 134: 147-156.
9. Kitawaki, J., T. Noguchi, T. Amatsu, et al. 1997. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol. Reprod. 57: 514-519.
10. Kitawaki, J., I. Kusuki, H. Koshiba, et al. 1999. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil. Steril. 72: 1100-1106.
11. Wölfler, M.M., F. Nagele, A. Kolbus, et al. 2005. A predictive model for endometriosis. Hum. Reprod. 20: 1702-1708.
12. Velasco, I., J. Rueda & Acién P. 2006. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol. Hum. Reprod. 12: 377-381.
13. Noble, L.S., E.R. Simpson, A. Johns & S.E. Bulun 1996. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81: 174-179.
14. Attar, E., H. Tokunaga, G. Imir, et al. 2009. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J. Clin. Endocrinol. Metab. 94: 623-631.
15. De Leon, F.D., R. Vijayakumar, C.V. Rao & M. Yussman 1988. Prostaglandin F2α and E2 release by peritoneum with and without endometriosis. Int. J. Fertil. 33: 48-51.
16. Huhtinen, K., R. Desai, M. Ståhle, et al. 2012. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J. Clin. Endocrinol. Metab. 97: 4228-4235.
17. Brandenberger, A.W., D.I. Lebovic, M.K. Tee, et al. 1999. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol. Hum. Reprod. 5: 651-655.
18. Cavallini, A., L. Resta, A.M. Caringella, et al. 2011. Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil. Steril. 96: 102-106.
19. Liu, A.J., Z. Guan, Z.M. Zhang, et al. 2008. Study on expression of estrogen receptor isoforms in eutopic and ectopic endometrium of ovarian endometriosis. Zhonghua. Bing. Li. Xue. Za. Zhi. 37: 584-588.
20. Fujimoto, J., R. Hirose, H. Sakaguchi & T. Tamaya 1999. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol. Hum. Reprod. 5: 742-747.
21. Bulun, S.E., D. Monsavais, M.E. Pavone, et al. 2012. Role of estrogen receptor-β in endometriosis. Semin. Reprod. Med. 30: 39-45.
22. Xue, Q., Z. Lin, Y.H. Cheng, et al. 2007. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol. Reprod. 77: 681-687.
23. Matsuzaki, S., T. Fukaya, S. Uehara, et al. 2000. Characterization of messenger RNA expression of estrogen receptor-alpha and -beta in patients with ovarian endometriosis. Fertil. Steril. 73: 1219-1225.
24. Matsuzaki, S., S. Uehara, T. Murakami, et al. 2000. Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay. Fertil. Steril. 74: 753-759.
25. Matsuzaki, S., T. Murakami, S. Uehara, et al. 2001. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil. Steril. 75: 1198-1205.
26. McLaren, J., A. Prentice, D.S. Charnock-Jones, et al. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98: 482-489.
27. You, H.J., J.Y. Kim & H.G. Jeong 2003. 17 beta-estradiol increases inducible nitric oxide synthase expression in macrophages. Biochem. Biophys. Res. Commun. 303: 1129-1134.
28. Capellino, S., P. Montagna, B. Villaggio, et al. 2006. Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis. Ann. N.Y. Acad Sci. 1069: 263-267.
29. Montagna, P., S. Capellino, B. Villaggio, et al. 2008. Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation. Fertil. Steril. 90: 156-164.
30. Ferrero, S., L.H. Abbamonte, P. Anserini, et al. 2005. Future perspectives in the medical treatment of endometriosis. Obstet. Gynecol. Surv. 60: 817-826.
31. Stratton, P., N. Sinaii, J. Segars, et al. 2008. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet. Gynecol. 111:88-96.
32. Hong, M. & Q. Zhu 2004. Macrophages are activated by 17beta-estradiol: possible permission role in endometriosis. Exp. Toxicol. Pathol. 55: 385-391.
33. Khan, K.N., H. Masuzaki, A. Fujishita, et al. 2005. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis. Hum. Reprod. 20: 2004-2013.
34. Kats, R., C.N. Metz & A. Akoum 2002. Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J. Clin. Endocrinol. Metab. 87: 883-889.
35. Morin, M., C. Bellehumeur, M.J. Therriault, et al. 2005. Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil. Steril. 83: 865-872.
36. Kats, R., T. Collette, C.N. Metz & A. Akoum 2002. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil. Steril. 78: 69-76.
37. Akoum, A., C.N. Metz, M. Al-Akoum & R. Kats 2006. Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil. Steril. 85: 1379-1385.
38. Veillat, V., V. Sengers, C.N. Metz, et al. 2012. Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis. Am. J. Pathol. 181: 917-927.
39. Ota, H., S. Igarashi, M. Sasaki & T. Tanaka 2001. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum. Reprod. 16: 561-566.
40. Bulun, S.E., Z. Lin, G. Imir, et al. 2005. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol. Rev. 57: 359-383.
41. Zeitoun, K.M. & S.E. Bulun 1999. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil. Steril. 72: 961-969.
42. Boucher, A., W. Mourad, J. Mailloux, et al. 2000. Ovarian hormones modulate monocyte chemotactic protein-1 expression in endometrial cells of women with endometriosis. Mol. Hum. Reprod. 6: 618-626.
43. Tamura, M., S. Sebastian, S. Yang, et al. 2002. Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J. Clin. Endocrinol. Metab. 87: 3263-3273.
44. Tamura, M., S. Sebastian, S. Yang, et al. 2002. Vascular endothelial growth factor upregulates cyclooxygenase-2 expression in human endothelial cells. J. Clin. Endocrinol. Metab. 87: 3504-3507.
45. Haney, A.F. & J.B. Weinberg 1988. Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate. Am. J. Obstet. Gynecol. 159: 450-454.
46. Leiva, M.C., L.A. Hasty, S. Pfeifer, et al. 1993. Increased chemotactic activity of peritoneal fluid in patients with endometriosis. Am. J. Obstet. Gynecol. 168: 592-598.
47. Taketani, Y., T.M. Kuo & M. Mizuno 1992. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am. J. Obstet. Gynecol. 167: 265-270.
48. Ferrero, S., D.J. Gillott, V. Remorgida, et al. 2009. GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis. J. Reprod. Med. 54: 223-231.
49. el-Roeiy, A., W.P. Dmowski, N. Gleicher, et al. 1988. Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil. Steril. 50: 864-871.
50. Ferrero, S., V. Remorgida, P.L. Venturini & U. Leone Roberti Maggiore 2014. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. Eur. J. Obstet. Gynecol. Reprod. Biol. 174: 117-122.
51. Lall Seal, S., G. Kamilya, J. Mukherji, et al. 2011. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil. Steril. 95: 291.e15-e18.
52. Remorgida, V., L.H. Abbamonte, N. Ragni, et al. 2007. Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil. Steril. 88: 724-726.
53. Hefler, L.A., C. Grimm, M. van Trotsenburg & F. Nagele 2005. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil. Steril. 84: 1033-1036.
54. Ferrero, S., E. Biscaldi, P.L. Venturini & V. Remorgida 2011. Aromatase inhibitors in the treatment of bladder endometriosis. Gynecol. Endocrinol. 27: 337-340.
55. Ferrero, S., G. Camerini, N. Ragni, et al. 2010. Letrozole and norethisterone acetate in colorectal endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 150: 199-202.
56. Ferrero, S., U. Leone Roberti Maggiore, C. Scala, et al. 2013. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. Arch. Gynecol. Obstet. 287: 447-453.
57. Ailawadi, R.K., S. Jobanputra, M. Kataria, et al. 2004. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil. Steril. 81: 290-296.
58. Ferrero, S., D.J. Gillott, P.L. Venturini & V. Remorgida 2011. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod. Biol. Endocrinol. 9: 89.
59. Ferrero, S., P.L. Venturini, N. Ragni, et al. 2009. Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 69: 943-952.
60. Remorgida, V., L.H. Abbamonte, N. Ragni, et al. 2007. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust. NZ J. Obstet. Gynaecol. 47: 222-225.
61. Ferrero, S., P.L Venturini & V. Remorgida 2010. Letrozole monotherapy in the treatment of uterine myomas. Fertil. Steril. 93: e31.